CureVac N.V (NASDAQ:CVAC)’s traded shares stood at 16.73 million during the latest session, with the company’s beta value hitting 2.49. At the last check today, the stock’s price was $5.60, to imply an increase of 37.56% or $1.53 in intraday trading. The CVAC share’s 52-week high remains $5.00, putting it 10.71% up since that peak but still an impressive 57.68% since price per share fell to its 52-week low of $2.37.
Analysts have given a consensus recommendation of Buy for CureVac N.V (CVAC), translating to a mean rating of 2.00. Of 2 analyst(s) looking at the stock, 0 analyst(s) give CVAC a Sell rating. 0 of those analysts rate the stock as Overweight while 0 advise Hold as 2 recommend it as a Buy.
CureVac N.V (NASDAQ:CVAC) trade information
After registering a 37.56% upside in the latest session, CureVac N.V (CVAC) has traded red over the past five days. The 5-day price performance for the stock is 25.53%, and 64.91% over 30 days. With these gigs, the year-to-date price performance is 64.19%.
The extremes give us $21 and $37 for target low and target high price respectively. As such, CVAC has been trading -560.71% off suggested target high and -275.0% from its likely low.
CVAC Dividends
CureVac N.V has its next earnings report out in July. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
The next major institution holding the largest number of shares is POINT72 ASSET MANAGEMENT, L.P. with 2.42 million shares, or about 1.0801% of shares outstanding. As of the market price on 2024-06-30, these shares were worth $8.24 million.
